22 - 28 February 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
The impact of caring on family members
An MS Society survey shows the degree of unpaid care being provided to people with MS by family members. Two in five provided more than 35 hours care a week and one in six said this was more than 90 hours. One in three respondents said they had given up work to care.
MS Trust link: It's hard to know which way to turn
Relapse risk when switching from Tysabri
Switching from Tysabri to another disease modifying drug didn't lead to an increase in relapses according to a US study of medical records. Previous studies had seen a risk of relapse when switching. People in this study started the new drug sooner (under two months) than in the previous study (four and half months), which may be the important factor
Source: MS News Today
MS Trust link: MS Decisions - a guide to disease modifying drugs for relapsing MS
MS in the Media
27 Nov 2020 - 00:00
- Depression affects multitasking in MS
- Benefits process in Scotland
- Cancer risks and multiple sclerosis
- Gut immune cells and relapses
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.